Medpace Holdings Price to Free Cash Flow Ratio 2014-2025 | MEDP
Historical price to free cash flow ratio values for Medpace Holdings (MEDP) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medpace Holdings Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-25 | 311.14 | 18.31 | |
| 2025-03-31 | 304.69 | $16.99 | 17.93 |
| 2024-12-31 | 332.23 | $17.88 | 18.59 |
| 2024-09-30 | 333.80 | $16.71 | 19.98 |
| 2024-06-30 | 411.85 | $15.69 | 26.25 |
| 2024-03-31 | 404.15 | $14.86 | 27.19 |
| 2023-12-31 | 306.53 | $12.46 | 24.60 |
| 2023-09-30 | 242.13 | $11.37 | 21.29 |
| 2023-06-30 | 240.17 | $11.38 | 21.11 |
| 2023-03-31 | 188.05 | $11.61 | 16.20 |
| 2022-12-31 | 212.41 | $10.43 | 20.37 |
| 2022-09-30 | 157.17 | $8.55 | 18.37 |
| 2022-06-30 | 149.67 | $7.02 | 21.33 |
| 2022-03-31 | 163.59 | $5.91 | 27.69 |
| 2021-12-31 | 217.64 | $6.24 | 34.90 |
| 2021-09-30 | 189.28 | $7.21 | 26.24 |
| 2021-06-30 | 176.63 | $6.78 | 26.06 |
| 2021-03-31 | 164.05 | $6.23 | 26.34 |
| 2020-12-31 | 139.20 | $6.03 | 23.09 |
| 2020-09-30 | 111.75 | $4.82 | 23.19 |
| 2020-06-30 | 93.02 | $5.00 | 18.59 |
| 2020-03-31 | 73.38 | $5.20 | 14.12 |
| 2019-12-31 | 84.06 | $4.90 | 17.17 |
| 2019-09-30 | 84.04 | $4.50 | 18.67 |
| 2019-06-30 | 65.42 | $4.31 | 15.18 |
| 2019-03-31 | 58.97 | $4.12 | 14.31 |
| 2018-12-31 | 52.93 | $3.81 | 13.90 |
| 2018-09-30 | 59.91 | $3.43 | 17.46 |
| 2018-06-30 | 43.00 | $3.07 | 14.03 |
| 2018-03-31 | 34.91 | $2.80 | 12.46 |
| 2017-12-31 | 36.26 | $2.15 | 16.86 |
| 2017-09-30 | 31.90 | $2.23 | 14.30 |
| 2017-06-30 | 29.00 | $2.73 | 10.61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.062B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.323B | 26.51 |
| CVS Health (CVS) | United States | $85.490B | 10.63 |
| Elevance Health (ELV) | United States | $85.046B | 10.97 |
| Cencora (COR) | United States | $57.007B | 19.83 |
| Natera (NTRA) | United States | $23.468B | 0.00 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Labcorp Holdings (LH) | United States | $21.974B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.262B | 0.00 |
| Solventum (SOLV) | United States | $12.973B | 13.73 |
| CochLear (CHEOY) | Australia | $12.633B | 0.00 |
| ICON (ICLR) | Ireland | $11.996B | 11.15 |
| Revvity (RVTY) | United States | $11.361B | 19.55 |
| Viatris (VTRS) | United States | $10.504B | 3.61 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| HealthEquity (HQY) | United States | $9.009B | 39.46 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.289B | 14.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.259B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.024B | 36.92 |
| Sotera Health (SHC) | United States | $3.191B | 18.13 |
| Alignment Healthcare (ALHC) | United States | $2.786B | 0.00 |
| Concentras Parent (CON) | United States | $2.716B | 15.70 |
| Surgery Partners (SGRY) | United States | $2.705B | 35.18 |
| GeneDx Holdings (WGS) | United States | $2.594B | 99.89 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| PACS (PACS) | United States | $1.928B | 0.00 |
| Ardent Health (ARDT) | United States | $1.887B | 8.04 |
| Progyny (PGNY) | United States | $1.822B | 40.11 |
| GoodRx Holdings (GDRX) | United States | $1.811B | 36.21 |
| Premier (PINC) | United States | $1.791B | 13.59 |
| Teladoc Health (TDOC) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.158B | 8.81 |
| CareDx (CDNA) | United States | $1.051B | 16.42 |
| Establishment Labs Holdings (ESTA) | $1.034B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.915B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.831B | 7.78 |
| Nutex Health (NUTX) | United States | $0.641B | 9.70 |
| LifeMD (LFMD) | United States | $0.639B | 0.00 |
| Embecta (EMBC) | United States | $0.597B | 4.02 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Omada Health (OMDA) | $0.404B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.237B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 28.83 |
| So-Young (SY) | China | $0.174B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.123B | 0.00 |
| OncoCyte (IMDX) | United States | $0.099B | 0.00 |
| KindlyMD (NAKA) | United States | $0.092B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |